COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS
Sl. Shepheard et al., COMPARISON OF THE EFFECTS OF SUMATRIPTAN AND THE NK1 ANTAGONIST CP-99,994 ON PLASMA EXTRAVASATION IN DURA-MATER AND C-FOS MESSENGER-RNA EXPRESSION IN TRIGEMINAL NUCLEUS CAUDALIS OF RATS, Neuropharmacology, 34(3), 1995, pp. 255-261
Dural plasma extravasation produced by electrical stimulation of the t
rigeminal ganglion was measured in rats and the concomitant expression
of c fos mRNA produced in the trigeminal nucleus caudalis (NtV) was m
easured using in situ hybridization techniques. The non-peptide NK1 re
ceptor selective antagonist CP-99,994 (1-3000 mu g kg(-1)) and the 5HT
(1D) receptor agonist sumatriptan (1-1000 mu g kg(-1)) reduced dural p
lasma extravasation dose-dependently with ID(50)s of 52 mu g kg(-1) an
d 30 mu g kg(-1) respectively. CP-99,994 (1000 mu g kg(-1)), a compoun
d known to have good brain penetration, decreased c-fos mRNA expressio
n in the NtV by 37 +/- 7% without disruption of the blood brain barrie
r (BBB). Sumatriptan (1000 mu g kg(-1)), known to be poorly brain pene
trant, had no significant effect on c-fos mRNA expression in the NtV u
nless the BBB was disrupted by infusion of a hyperosmolar mannitol sol
ution after which sumatriptan decreased c-fos mRNA expression by 65 +/
- 11%. The results suggest that brain penetrant NK1 receptor antagonis
ts may have anti-migraine effects peripherally through blockade of dur
al extravasation and centrally by inhibition of nociceptive pathways.
Furthermore the data indicates that the anti-migraine action of sumatr
iptan must be predominantly peripherally mediated, be it via inhibitio
n of plasma extravasation or direct vasoconstriction, since it had lit
tle effect on the activation of neurones in the NtV unless the BBB was
disrupted.